Skip to content
DataLookout
Menu

NCT05129345

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 7 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 3 words Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 122 participants (planned 150)
    • Primary completion date changed from estimate of Oct 31, 2026 to Jan 31, 2023
    • Site details revised at 2 of 2 sites
  2. Notable Primary completion date: Jun 2025 to Oct 31, 2026
    • Study completion date: Jun 2025 to Dec 31, 2026
    v9
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Jul 2022 to Jun 7, 2022
    v5
  4. Notable Primary and study completion dates: Mar 2023 to Jun 2025
    • Start date: Apr 2022 to Jul 2022
    v4
  5. Minor Primary and study completion dates: Feb 2023 to Mar 2023
    • Start date: Mar 2022 to Apr 2022
    v3
  6. Minor Primary and study completion dates: Dec 2022 to Feb 2023
    • Start date: Jan 2022 to Mar 2022
    v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Aim 1: Number of social determinants of cardiometabolic health identified from interviews
Timeframe: 2 weeks after enrollment
Aim 2: Patient engagement in healthcare as measured by the Patient Activation Measure (PAM)
Timeframe: Baseline
Aim 3: Number of strategies modified in the self-management support and education
Timeframe: Up to 3 months

Arms and interventions

Aim 1

People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes. All genders, races and ethnicities will be included in this study. Subjects will have a telephone visit including being consented electronically and complete a demographic survey, a photography training visit and an interview visit.

Aim 2

People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes. All genders, races and ethnicities will be included in this study. Subjects will have a telephone visit and be electronically consented to study and complete an electronic survey.

Aim 3

Group composed of 10 willing participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. There will be 3 one hour meetings over 3 months.

Sites

2 sites in 1 country